Search

Search Results

• GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients

  Lidia Wydeheft , Justyna Jusiak , Paulina Halik, Paulina Malon, Kornelia Kędziora-Kornatowska

  67673

  2026-01-10
• Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety

  Michał Stasiak, Wiktor Żyro, Karolina Woźniak, Katarzyna Żyro, Franciszek Glapiński, Adam Woźniak

  60634

  2025-06-17
• The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review

  Kamil Turlej, Dmytro Kowalczuk, Viktoryia Kasianik, Darya Lazitskaya, Mykola Sobchynskyi, Valeryia Milasheuskaya, Andrii Myrnyi, Iga Kiełbaszewska, Natallia Surosz, Katsiaryna Miraniuk

  61264

  2025-07-07
• Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review

  Karolina Baran, Marlena Jankowska, Natalia Jańczyk, Karolina Mędrysa, Jakub Pokrzepa, Michał Presak, Gabriela Blecharz, Julia Szwech, Alicja Winkowska, Jan Machalica

  56469

  2024-12-26
• Dietary Modulation and Clinical Outcomes During GLP-1 Receptor Agonist Therapy. A Literature Review

  Kacper Rychlica, Konrad Gawin, Wiktoria Zawiślak, Anita Ignasiak, Michał Cisowski, Maria Dąbrowska, Jolanta Cholewińska-Rychlica, Paulina Madura, Daria Mrozik-Gałecka

  67649

  2026-01-18
• Therapeutic Spectrum of GLP-1 Receptor Agonist: From Glycemic Control to Metabolic Protection

  Marta Kamińska, Wiktoria Kotlarz, Matylda Kuczma, Adrianna Klimczak, Barbara Pietrzak, Mikołaj Patelski, Maciej Czapla, Mateusz Surma, Wiktoria Mikusek, Jakub Molenda

  68001

  2026-01-17
• Neuroprotective Mechanisms of GLP‑1 Pathway Activation in Parkinson’s Disease - Foundations For Future Disease‑Modifying Strategies

  Gabriela Chmiel, Patryk Bachurski, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Paweł Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68253

  2026-02-01
• Beyond Glycemic Control: The Expanding Role of GLP-1 Analogues in Type 2 Diabetes and Metabolic Health

  Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła

  56722

  2024-12-20
• Injections for weight loss: what’s new in GLP-1 RAs for obesity treatment – review

  Małgorzata Maria Zając, Radosław Zaucha, Julia Silldorff, Stanisław Anczyk, Marcin Dudek, Tomasz Fura, Zuzanna Felińska, Oliwia Iszczuk, Magdalena Gajkiewicz, Magdalena Jaskółka

  53875

  2024-08-19